Overview

VNA and PACS Market is estimated to value over USD 4.5 billion by 2027 end with a CAGR of over 7% during the forecast period 2020 to 2027.

Healthcare organizations are innovating in creating affordable care services and meeting the needs of value-based payments. VNA and PACS enable the healthcare systems for efficient management of medical images, streamlining business and clinical workflows. These methods shall help healthcare providers in improving the treatment quality, reducing costs, increasing efficiency and shifting resources for innovation. Furthermore, increased grants and investments by companies and government bodies in medical imaging plays a crucial role in implementing these imaging technologies, improving a patient’s quality of life, modernizing imaging facilities. For example, the European Investment Bank in November 2017 announced that they will provide a financial assistance of over EUR 25 million to a Berlin-based company, Medneo Group, offering novel imaging diagnostics technology and services. Such investments in the field of medical imaging is primarily responsible for the VNA and PACS market growth.
There has been a surge in the usage of AI in medical imaging. Major market players are developing in-house AI solutions to promote them as integrated or supplementary offerings with their marquee HCIT products. Since 2015, over 40 start-ups developing machine learning and AI-based medical imaging solutions have entered the market. Such a booming demand for AI has aided in the proliferation of the market. 

Market Segmentation:

By Procurement
•    Departmental PACS
•    Enterprise PACS 
•    Departmental VNA
•    Enterprise VNA
By Delivery Mode 
•    On-Premise VNA
•    Hybrid VNA
•    Fully Cloud-Based VNA
By End User 
•    Hospitals
•    Diagnostic Imaging Centers 
•    Diagnostic Centre    
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is classified into procurement, delivery mode, end user and region. The department segment is fragmented into cardiology, radiology, pathology, ortho and oncology. The departmental PACS segment is predicted to hold the largest VNA and PACS market share and this can be credited to an rising pressure of improving the care quality, increasing efforts for enhancing the patient experience keeping the cost as low as possible, a wide range of imaging applications in radiology, escalating rise in storing, indexing, sharing and capturing medical images. The delivery mode is categorised into hybrid VNA, fully cloud based VNAs and on-premise VNAs. The on-premise VNAs lead the market revenue-wise owing to an increasing preference for this mode over others. This is due to high security and better data control offered by on-premise VNA solutions. However, the hybrid VNAs are predicted to grow at a significant rate during the forecast period. 

Regional Analysis:

The North America region dominated the market and it is predicted to continue its domination throughout the forecast period. This is mainly due to programs like Healthcare Insurance Portability and Accountability, advancements in medical imaging technologies and rising adoption of PACS and VNAs in hospitals and other healthcare settings.

Competitive Landscape:                            

Some of the key market players are Agfa HealthCare, BridgeHead Software Limited, Carestream Health, Inc., FUJIFILM Medical Systems U.S.A., GE Healthcare, Hyland Software Inc., Merge Healthcare Inc. (IBM), Mach7 Technologies, McKesson Corporation (Change Healthcare), Novarad Corporation, Koninklijke Philips N.V., Siemens Healthineers, Sectra AB, and INFINITT Healthcare CO.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global VNA and PACS market by procurement, by delivery mode by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions     

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
          1.1 Objectives of the Study 
          1.2 Market Definition 
          1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
          1.4 Currency
          1.5 Limitations 
          1.6 Stakeholders 
 2.  Research Methodology 
          2.1 Research Data 
               2.1.1 Secondary Data
                        2.1.1.1 Key Data from Secondary Sources
               2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
          2.2 Market Size Estimation 
          2.3 Market Breakdown and Data Triangulation 
          2.4 Assumptions for the Study  
3. Executive Summary
          3.1 Market Outlook
          3.2 Segment Outlook
          3.3 Competitive Insights
4. Market Variables, Trends & Scope
          4.1 Market Lineage Outlook
          4.2 Penetration and Growth Prospect Mapping
          4.3 Industry Value Chain Analysis
          4.4 Cost Analysis Breakdown
          4.5 Technology Overview
          4.6 Regulatory Framework on Country Level
                4.6.1 Reimbursement Framework    
                4.6.2 Standards and Compliances
5. Market Overview
          5.1 Market Dynamics
                 5.1.1 Market Driver Analysis         
                 5.1.2 Market Restraint Analysis         
                 5.1.3 Industry Challenges                   
6. Market Analysis tools                       
          6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
          6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. VNA and PACS Market, By Procurement Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
          7.1 Departmental PACS
                7.1.1 Radiology PACS
                7.1.2 Cardiology PACS
                7.1.3 Other Departments 
          7.2 Enterprise PACS 
          7.3 Departmental VNA
          7.4 Enterprise VNA
                7.4.1 Multi-Departmental VNA
                7.4.2 Multi Site VNA                                        
8. VNA and PACS Market, By Delivery Model Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
          8.1 On-Premise VNA
          8.2 Hybrid VNA
          8.3 Fully Cloud-Based VNA
9. VNA and PACS Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
          9.1 Hospitals
          9.2 Diagnostic Imaging Centers 
          9.3 Diagnostic Centre                    
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          10.1. Introduction
          10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                10.2.1. U.S.
                10.2.2. Canada
                10.2.3. Mexico
                10.2.3 Rest of North America
          10.3 Market Size (USD Mn) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          11.1. Introduction
          11.2. Regional Market Trends
          11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                11.3.1. Brazil
                11.3.2. Uruguay
                11.3.3 Argentina
                11.3.4. Rest of Latin America
          11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          12.1. Introduction
          12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.2.1. Germany
                12.2.2. U.K
                12.2.3. France
                12.2.4. Italy
                12.2.5 Switzerland
                12.2.6. Spain
                12.2.7. Russia
                12.2.8. Poland
                12.2.9. Rest of Western Europe
          12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          13.1 Introduction
          13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 13.2.1 Japan
                 13.2.2 China
                 13.2.3 Singapore
                 13.2.4 Korea         
                 13.2.5 India
                 13.2.6 Australia and New Zealand
                 13.2.7 ASEAN
                 13.2.8 Rest of Asia Pacific
          13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          14.1 Introduction
          14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
              14.2.1 UAE
              14.2.2 South Africa
              14.2.3 Egypt
              14.2.4 Saudi Arabia
              14.2.5 Rest of MEA
          14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    15.1 Agfa HealthCare
            15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.1.2. Product Portfolio
            15.1.3. SWOT Analysis
            15.1.4. Financial Overview
            15.1.5. Strategic Overview
    15.2 BridgeHead Software Limited
            15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.2. Product Portfolio
            15.2.3. SWOT Analysis
            15.2.4. Financial Overview
            15.2.5. Strategic Overview
    15.3 FUJIFILM Medical Systems U.S.A.
            15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2. Product Portfolio
            15.3.3. SWOT Analysis
            15.3.4. Financial Overview
            15.3.5. Strategic Overview
    15.4 GE Healthcare
            15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.4.2. Product Portfolio
            15.4.3. SWOT Analysis
            15.4.4. Financial Overview
            15.4.5. Strategic Overview
    15.5 Hyland Software Inc.
            15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.5.2. Product Portfolio
            15.5.3. SWOT Analysis
            15.5.4. Financial Overview
            15.5.5. Strategic Overview
    15.6 Merge Healthcare Inc. (IBM)
            15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.6.2. Product Portfolio
            15.6.3. SWOT Analysis
            15.6.4. Financial Overview
            15.6.5. Strategic Overview
    15.7 Mach7 Technologies
            15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.7.2. Product Portfolio
            15.7.3. SWOT Analysis
            15.7.4. Financial Overview
            15.7.5. Strategic Overview
    15.8 McKesson Corporation (Change Healthcare)
            15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.8.2. Product Portfolio
            15.8.3. SWOT Analysis
            15.8.4. Financial Overview
            15.8.5. Strategic Overview    
    15.9 Novarad Corporation
            15.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.9.2. Product Portfolio
            15.9.3. SWOT Analysis
            15.9.4. Financial Overview
            15.9.5. Strategic Overview
    15.10 Koninklijke Philips N.V.
            15.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.10.2. Product Portfolio
            15.10.3. SWOT Analysis
            15.10.4. Financial Overview
            15.10.5. Strategic Overview
    15.11 Siemens Healthineers
            15.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.11.2. Product Portfolio
            15.11.3. SWOT Analysis
            15.11.4. Financial Overview
            15.11.5. Strategic Overview
16. Impact of COVID-19
      16.1. Positive influence on the healthcare industry
      16.2. The financial disruption of the manufacturing sector
      16.3. Impact of COVID-19 on emerging companies
      16.4. Significant mandates in the healthcare regulations initiated by administrations
      16.5. The overall economic slowdown of the developing and developed nations
17. Competitive Intelligence and Competitive Matrix
      17.1 Competitive Intelligence
      17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis
      18.1 Joint ventures
      18.2 Mergers and acquisitions
      18.3 Licensing and partnerships 
      18.4 Technology Collaborations
      18.5 Strategic Divestments
      18.6 Market Entry Strategies                     
19. Relevant Case Studies and Latest News Updates
20. Research Sources and List of Primary Contacts of this Study
21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics 

Tables

Figures